fda compounding semaglutide warning 2025 october Compounded "semaglutide" is not FDA-approved February 17, 2026: Pennsylvania compounding
Description
Novo Nordisk Announces FDA Approval of Label Update for Rybelsus (semaglutide) Allowing Use as a First-Line Option for Adults With Type 2 Diabetes
Not everybody is eligible for GLP-1 medications
Remove the needle and discard the pen: After the injection, remove the needle from your skin and discard the pen in a sharps container
Call your doctor if the nausea is extreme or is not fading as time passes
If one site causes persistent discomfort, switching to another approved area is perfectly acceptable consult your healthcare provider for personalized guidance
Nutrients 15 (24), 5096
